| Q40612339 | Activation and inhibition of mediator release from skin mast cells: a review of in vitro experiments |
| Q34444328 | Activation of Ca2+ signaling in neutrophils by the mast cell-released immunophilin FKBP12 |
| Q71602259 | Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells |
| Q33598696 | Airway nerves and protein phosphatases. |
| Q50685651 | Calcineurin activation is only one calcium-dependent step in cytotoxic T lymphocyte granule exocytosis. |
| Q28277749 | Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes |
| Q70901396 | Calmodulin is the divalent cation receptor for rapid endocytosis, but not exocytosis, in adrenal chromaffin cells |
| Q39291738 | Cathepsin G induces cell aggregation of human breast cancer MCF-7 cells via a 2-step mechanism: catalytic site-independent binding to the cell surface and enzymatic activity-dependent induction of the cell aggregation |
| Q41614974 | Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin |
| Q29031637 | Cyclophilin-dependent stimulation of transcription by cyclosporin A |
| Q46320823 | Cyclosporine and the renin-angiotensin axis |
| Q70785785 | Effect of cyclosporin analogues on histamine release from rat peritoneal mast cells and rat basophilic leukaemia cells |
| Q71621319 | Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells |
| Q37199196 | Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12 |
| Q44491856 | Effects of immunomodulators on airways hyperresponsiveness to adenosine induced in actively sensitised Brown Norway rats by exposure to allergen |
| Q41891469 | Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro |
| Q37892648 | FK-506-binding proteins from streptomycetes producing immunosuppressive macrolactones of the FK-506 type |
| Q42806438 | FR177391, a new anti-hyperlipidemic agent from Serratia. IV. Target identification and validation by chemical genetic approaches |
| Q37278664 | FcepsilonRI-induced activation by low antigen concentrations results in nuclear signals in the absence of degranulation |
| Q38293510 | FcϵRI-mediated Induction of Nuclear Factor of Activated T-cells |
| Q47753644 | Global environmental pollutant substance vanadium activates mast cells and basophils at the late phase in the presence of hydrogen peroxide |
| Q43228328 | Hemorphins act as homeostatic agents in response to endotoxin-induced stress |
| Q48445337 | High brain densities of the immunophilin FKBP colocalized with calcineurin |
| Q44280701 | Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis‐trans isomerase in a secretagogue specific manner |
| Q41941546 | Immunophilin regulation of neurotransmitter release |
| Q40429841 | Immunophilins and nervous system |
| Q41820295 | Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation |
| Q39473333 | In Vitro Fusion of Reticulocyte Endocytic Vesicles with Liposomes |
| Q41837128 | Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice |
| Q40743752 | Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel |
| Q36184530 | Mast cell tumor necrosis factor alpha production is regulated by MEK kinases |
| Q24321585 | Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13 |
| Q34701373 | New developments in immunosuppressive therapy in renal transplantation |
| Q53022050 | Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations |
| Q24336264 | Purification and characterization of a novel physiological substrate for calcineurin in mammalian cells |
| Q34275901 | Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors |
| Q40841533 | Rapamycin: in vitro profile of a new immunosuppressive macrolide |
| Q42597910 | Saccharomyces cerevisiae contains a homolog of human fkbp‐13, a membrane‐associated fk506/rapamycin binding protein |
| Q28273170 | Solution Structure of FKBP, a Rotamase Enzyme and Receptor for FK506 and Rapamycin |
| Q43187221 | Stimulation of airway sensory nerves by cyclosporin A and FK506 in guinea-pig isolated bronchus. |
| Q33744081 | Tacrolimus (FK 506). |
| Q40385566 | Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation |
| Q36695966 | The Immunosuppressant FK506 Inhibits Amino Acid Import in Saccharomyces cerevisiae |
| Q28268061 | The concept of synthetic lethality in the context of anticancer therapy |
| Q37373982 | The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines |
| Q40486256 | Unexpected side chain effects at residue 8 of cyclosporin a derivatives allow photoswitching of immunosuppression. |